Gazyva

Gazyva Indications/Uses

obinutuzumab

Manufacturer:

Roche

Distributor:

DKSH
Full Prescribing Info
Indications/Uses
Chronic Lymphocytic Leukaemia: GAZYVA in combination with chlorambucil is indicated for the treatment of patients with previously untreated chronic lymphocytic leukaemia (CLL).
Follicular Lymphoma: GAZYVA in combination with chemotherapy, followed by GAZYVA maintenance is indicated for the treatment of patients with previously untreated follicular lymphoma.
GAZYVA in combination with bendamustine, followed by GAZYVA maintenance is indicated for the treatment of patients with follicular lymphoma (FL) who did not respond to, or who progressed during or after treatment with rituximab or a rituximab-containing regimen.
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in